RESUMO
Background Preeclampsia is a prominent risk factor for long-term development of cardiovascular disease. Although existing studies report a strong correlation between preeclampsia and heart failure, the underlying mechanisms are poorly understood. One possibility is the glycoprotein growth factor activin A. During pregnancy, elevated activin A levels are associated with impaired cardiac global longitudinal strain at 1 year, but whether these changes persist beyond 1 year is not known. We hypothesized that activin A levels would remain increased more than 1 year after a preeclamptic pregnancy and correlate with impaired cardiac function. Methods and Results To test our hypothesis, we performed echocardiograms and measured activin A levels in women approximately 10 years after an uncomplicated pregnancy (n=25) or a pregnancy complicated by preeclampsia (n=21). Compared with women with a previously normal pregnancy, women with preeclampsia had worse global longitudinal strain (-18.3% versus -21.3%, P=0.001), left ventricular posterior wall thickness (0.91 mm versus 0.80 mm, P=0.003), and interventricular septal thickness (0.96 mm versus 0.81 mm, P=0.0002). Women with preeclampsia also had higher levels of activin A (0.52 versus 0.37 ng/mL, P=0.02) and activin/follistatin-like 3 ratio (0.03 versus 0.02, P=0.04). In a multivariable model, the relationship between activin A levels and worsening global longitudinal strain persisted after adjusting for age at enrollment, mean arterial pressure, race, and body mass index (P=0.003). Conclusions Our findings suggest that both activin A levels and global longitudinal strain are elevated 10 years after a pregnancy complicated by preeclampsia. Future studies are needed to better understand the relationship between preeclampsia, activin A, and long-term cardiac function.
Assuntos
Cardiopatias/etiologia , Ventrículos do Coração/fisiopatologia , Contração Miocárdica/fisiologia , Período Pós-Parto/fisiologia , Pré-Eclâmpsia/fisiopatologia , Função Ventricular Esquerda/fisiologia , Ativinas/sangue , Adulto , Biomarcadores/sangue , Ecocardiografia , Feminino , Seguimentos , Cardiopatias/diagnóstico , Cardiopatias/fisiopatologia , Ventrículos do Coração/diagnóstico por imagem , Humanos , Pré-Eclâmpsia/sangue , Pré-Eclâmpsia/diagnóstico , Gravidez , Prognóstico , Estudos Retrospectivos , Fatores de TempoAssuntos
Ecocardiografia/instrumentação , Monitorização Intraoperatória/instrumentação , Sistemas Automatizados de Assistência Junto ao Leito , Hemorragia Uterina/cirurgia , Obstrução do Fluxo Ventricular Externo/diagnóstico por imagem , Feminino , Humanos , Cirrose Hepática/complicações , Cirrose Hepática/patologia , Pessoa de Meia-Idade , Monitorização Intraoperatória/métodos , Hepatopatia Gordurosa não Alcoólica/patologia , Ressuscitação , Hemorragia Uterina/etiologia , Obstrução do Fluxo Ventricular Externo/etiologia , Obstrução do Fluxo Ventricular Externo/terapiaRESUMO
This case report describes mild anaemia and intravascular haemolysis in an otherwise healthy 41-year-old ultramarathon runner. In long-distance endurance athletes, trace gastrointestinal bleeding and plasma volume expansion are recognised sources of mild anaemia, often found incidentally. However, repetitive forceful foot striking can lead to blood cell lysis in the feet, resulting in a mild macrocytic anaemia and intravascular haemolysis, as was demonstrated in the patient described herein. Mild anaemia in runners, often called 'runner's pseudoanaemia', is typically clinically insignificant and does not require intervention. However, an unexplained anaemia can cause undue worry for otherwise healthy patients and lead to costly further testing, providing an argument against routine testing with complete blood counts in healthy, asymptomatic patients.